BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao SH, Yun H, Chen CZ, Chen YY, Lin JY, Zeng MS, Liu TS, Pan CZ, Jin H. The prognostic value of global myocardium strain by CMR-feature tracking in immune checkpoint inhibitor-associated myocarditis. Eur Radiol 2022;32:7657-67. [PMID: 35567603 DOI: 10.1007/s00330-022-08844-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ky B, Wilcox NS. Myocardial Strain Is Not in Vain: Predicting Cardiovascular Risk in Checkpoint Inhibitor Myocarditis. JACC Cardiovasc Imaging 2022;15:1897-9. [PMID: 36357132 DOI: 10.1016/j.jcmg.2022.08.008] [Reference Citation Analysis]
2 Irabor OC, Nelson N, Shah Y, Niazi MK, Poiset S, Storozynsky E, Singla DK, Hooper DC, Lu B. Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors. Front Oncol 2022;12:940127. [DOI: 10.3389/fonc.2022.940127] [Reference Citation Analysis]
3 Ji H, Wen Z, Liu B, Chen H, Lin Q, Chen Z. Sintilimab induced ICIAM in the treatment of advanced HCC: A case report and analysis of research progress. Front Immunol 2022;13:995121. [DOI: 10.3389/fimmu.2022.995121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]